BiotechTube
NextSource Pharma

NextSource Pharma

New York, United States· Est.
nextsourcepharma.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Azurity Pharmaceuticals is a US-based, private specialty pharma company founded in 2018, with a core mission of serving overlooked patients through customized drug formulations. It has built a commercial-stage portfolio of over 50 products, spanning key therapeutic areas, and utilizes a Next-Gen Commercial Model powered by data, analytics, and AI-driven tools. The company has a global footprint in over 50 countries and recently launched new products like Ferabright and Arynta, demonstrating ongoing pipeline execution and commercial growth.

Neurology/PsychiatryHematology/OncologyRadiology/Imaging

Technology Platform

Next-Gen Commercial Model leveraging data, analytics, and AI-driven digital tools for market reach and stakeholder engagement; expertise in customized drug formulations.

Opportunities

Significant opportunity in serving overlooked patient populations requiring alternative dosage forms, such as pediatric and geriatric patients.
Growth is fueled by recent product launches in large markets like ADHD treatment and diagnostic imaging, and the expansion of its global commercial footprint.

Risk Factors

Revenue concentration risk from a focused portfolio, regulatory and safety risks associated with specialized products (including boxed warnings), and dependence on a technology-driven commercial model vulnerable to data privacy and cybersecurity challenges.

Competitive Landscape

Azurity competes in niche segments of the specialty pharma market, often avoiding direct competition with large mass-market drugs. Key competitors include other specialty pharmaceutical companies focused on alternative dosage forms and generic/branded manufacturers in specific therapeutic areas like ADHD (e.g., Takeda's Vyvanse) and contrast agents (e.g., GE Healthcare, Bracco).

More companies in Biologics / Biosimilars →More companies in United States →